
Continuing efforts to increase visibility into the clinical trial process have resulted in a number of proposed and final regulations, guidance documents, and principles for the sharing of both study-level and patient-level clinical data. In this webinar, industry leaders will review the current content and status of the different requirements and recommendations for data-sharing from the EMEA, FDA and PhRMA. This review will assist attendees in determining the necessary steps to navigate through the complicated field of data transparency and to assure compliance.
Speak With Our Experts